Clinical trialNAUnknown
Percutaneous Versus EUS FNAC in Pancreatic Masses
Percutaneous Versus Endoscopic Guided Fine Needle Aspiration Cytology in Diagnosis of Pancreatic Masses
- Outcome
- Outcome unknown
- Phase
- NA
- Status
- Unknown
- Study type
- Interventional
- Start
- December 2021
- Expected end
- March 2023
- Enrollment
- 50 participants
- Sites
- 0
- Primary outcomes
- Yield, as defined by the percentage of patients in whom a histologically interpretable specimen will be retrieved by Trans abdominal US-FNAC. diagnostic accuracy
- Sponsor
- Other
- Results posted
- No
- Last update
- 14 June 2021
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try